DCCT, Diabetes Control and Complications Trial

You have access
Effect of Glycemic Exposure on the Risk of Microvascular Complications in the Diabetes Control and Complications Trial—Revisited
John M. Lachin, Saul Genuth, David M. Nathan, Bernard Zinman, Brandy N. Rutledge

Diabetes Apr 2008, 57 (4) 995-1001; DOI: 10.2337/db07-1618
You have access
Multiple Variants in Vascular Endothelial Growth Factor (VEGFA) Are Risk Factors for Time to Severe Retinopathy in Type 1 Diabetes
Hussam Al-Kateb, Lucia Mirea, Xinlei Xie, Lei Sun, Michelle Liu, Hongtao Chen, Shelley B. Bull, Andrew P. Boright, Andrew D. Paterson

Diabetes Aug 2007, 56 (8) 2161-2168; DOI: 10.2337/db07-0376
You have access
Diabetic Retinopathy
David A. Antonetti, Alistair J. Barber, Sarah K. Bronson, Willard M. Freeman, Thomas W. Gardner, Leonard S. Jefferson, Mark Kester, Scot R. Kimball, J. Kyle Krady, Kathryn F. LaNoue, Christopher C. Norbury, Patrick G. Quinn, Lakshman Sandirasegarane, Ian A. Simpson

Diabetes Sep 2006, 55 (9) 2401-2411; DOI: 10.2337/db05-1635
You have access
Glycation and Carboxymethyllysine Levels in Skin Collagen Predict the Risk of Future 10-Year Progression of Diabetic Retinopathy and Nephropathy in the Diabetes Control and Complications Trial and Epidemiology of Diabetes Interventions and Complications Participants With Type 1 Diabetes
Saul Genuth, Wanjie Sun, Patricia Cleary, David R. Sell, William Dahms, John Malone, William Sivitz, Vincent M. Monnier, for the DCCT Skin Collagen Ancillary Study Group*

Diabetes Nov 2005, 54 (11) 3103-3111; DOI: 10.2337/diabetes.54.11.3103

Main menu

User menu

Search

DCCT, Diabetes Control and Complications Trial

Navigate

More Information

Other ADA Resources